fibrinogen has been researched along with Critical Illness in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (9.30) | 18.2507 |
2000's | 5 (11.63) | 29.6817 |
2010's | 11 (25.58) | 24.3611 |
2020's | 23 (53.49) | 2.80 |
Authors | Studies |
---|---|
Acevedo, V; Álvarez, P; Aroca, P; Carvajal, C; Cofré, F; Mackenney, J; Montes, V; Poli, C; Soto, V; Tapia, L; Verdugo, P | 1 |
Chen, Y; Hu, H; Li, C; Xia, W; Yao, X; Zhang, Y | 1 |
Cabrera-Garcia, D; Harrison, NL; Houck, PJ; Miltiades, A; Monteleone, M; Roh, D; Wagener, G | 1 |
Brandão, LR; Faustino, EVS; Hanson, SJ; Karam, O; Monagle, P; Parker, RI | 1 |
Abdullayev, R; Bilgili, B; Cinel, I; Gul, F; Seven, S | 1 |
Czempik, PF; Herzyk, J; Krzych, ŁJ; Wilczek, D | 1 |
Chen, M; Chen, S; Jiang, T; Si, S; Xia, Y; Yao, C; Zhang, G; Zhang, L; Zhang, X; Zhu, Y | 1 |
Brubaker, LS; Cebula, A; Cruz, MA; Lam, FW; Loor, M; Martinez-Vargas, M; Rosengart, TK; Rumbaut, RE; Seshadri, N; Yee, A | 1 |
Chen, M; Chen, S; Li, R; Sun, J; Sun, S; Xia, Y; Yao, C; Zhang, G; Zhang, L; Zhang, N | 1 |
Ahn, J; Albizua, I; Anderson, EJ; Arthur, CM; Bosinger, SE; Bowen, T; Chahroudi, A; Chandler, JD; Druzak, S; Fibben, KS; Geller, R; Iffrig, E; Ivanova, AA; Kim, SO; Kulpa, DA; Lam, WA; Liu, X; Maier, CL; Maner-Smith, K; Mosunjac, M; Ortlund, EA; Paiardini, M; Roback, JD; Roberts, AM; Roberts, BR; Rostad, CA; Sakurai, Y; Schneider, F; Silvestri, G; Stowell, SR; Verkerke, HP; Wong, AKH; Zhang, T | 1 |
Bai, T; Chen, C; Peng, T; Wang, L; Wu, X; Zhang, N; Zhang, T | 1 |
Guo, L; Hu, Y; Yang, X; Zeng, Q | 1 |
Gong, L; Huang, J; Li, X; Lu, X; Luo, T; Tang, M; Tang, Z; Xiao, Z; Xie, L; Yan, H; Yang, Y; Yao, Z; Zang, P; Zhang, X; Zheng, M; Zhu, D | 1 |
Arellano-Orden, V; Casado-Méndez, M; Díaz-Martín, A; Dusseck-Brutus, R; Fernandez-Pacheco, J; Leal-Noval, SR; Pastor de Las Heras, Á; Pérez-Torres, I; Rodríguez-Martorell, FJ | 1 |
Chow, JH; Galvagno, S; Grazioli, A; Herr, D; Madathil, R; Mazzeffi, M; Menaker, J; Menne, A; Rabin, J; Scalea, T; Tabatabai, A; Tanaka, K | 1 |
Dong, Y; Guo, W; Li, Y; Ma, X; Shi, D; Song, L; Xu, M; Zhang, X | 1 |
Jhang, WK; Park, SJ | 1 |
Altmayer, V; Cao, A; Demeret, S; Gallo, A; Le Guennec, L; Marois, C; Rohaut, B; Saheb, S; Weiss, N | 1 |
Besser, M; Bridgeman, C; Cox-Morton, S; Duff, E; Edwards, T; Hayman, M; Kirk, M; MacDonald, S; Mahajan, S; Moore, C; Sharp, M; Thomas, W; White, D; Williams, R | 1 |
Bonnin, P; Chousterman, BG; Delrue, M; Deye, N; Ketfi, C; Malissin, I; Mebazaa, A; Mégarbane, B; Neuwirth, M; Siguret, V; Stépanian, A; Voicu, S | 1 |
Alsobrooks, JP; Budnick, IM; Davis, JPE; Intagliata, NM; Konkol, SB; Lau, CE; Lisman, T; Northup, PG; Stotts, MJ; Sundararaghavan, A | 1 |
Bazine, M; Cholley, B; Clausse, D; Godier, A; Hamada, SR; Huche, F; Lang, E; Meslin, S | 1 |
He, Y; Meng, Z; Zhao, Y | 1 |
Dujardin, RWG; Juffermans, NP; Müller, MCA; Thachil, J; van Mierlo, G; Zeerleder, SS | 1 |
Bilker, WB; Coffin, SE; Fuchs, BD; Garrigan, C; Gerber, JS; Han, JH; Han, X; Kelly, BJ; Lautenbach, E; Nachamkin, I; Tolomeo, P; Wise, J | 1 |
Balakrishnan, A; Culler, CA; Guillaumin, J; Yaxley, PE | 1 |
Douka, E; Ekonomidou, F; Giamarellou, H; Karaiskos, I; Kokkoris, S; Routsi, C | 1 |
Bonnevier, J; Kander, T; Larsson, A; Schött, U; Tynngård, N | 1 |
Frechen, S; Frey, L; Fuhr, U; Holdt, LM; Maier, B; Scharf, C; Taubert, M; Vogeser, M; Zander, J; Zoller, M | 1 |
Artaud-Macari, E; Beduneau, G; Besnier, E; Buchonnet, G; Carpentier, D; Dehay, J; Girault, C; Grangé, S; Guerrot, D; Marchalot, A; Tamion, F | 1 |
Borggrefe, M; Dempfle, CE; Elmas, E; Kälsch, T; Lücke, T; Münch, E; Suvajac, N | 1 |
Jen, H; Shew, S | 1 |
Egi, M; Iwasaki, T; Kanazawa, T; Matsusaki, T; Morimatsu, H; Morita, K; Shimizu, K; Suzuki, S; Tani, M; Toda, Y; Wiedermann, CJ | 1 |
Armaganidis, A; Bonovas, S; Dimopoulou, I; Kopterides, P; Markatos, C; Orfanos, S; Rapti, E; Travlou, A; Tsangaris, I; Tsantes, AE | 1 |
Brand, K; Haubitz, M; Herget-Rosenthal, S; Kirsch, T; Mentes, E; Metzger, J; Mischak, H; Schiffer, E; Ulger, P; Weissinger, EM | 1 |
Ho, KM; Leonard, AD | 1 |
Hall, DP; Lone, NI; Stanworth, SJ; Walsh, TS; Watson, DM | 1 |
Gando, S; Hayakawa, M; Hoshino, H; Kubota, N; Oshiro, A; Sawamura, A | 1 |
Doberer, D; Dunkler, D; Fuhrmann, V; Funk, GC; Kneidinger, N; Lindner, G; Schneeweiss, B | 1 |
Lowe, GD; Pollock, JG; Rumley, A; Woodburn, KR | 1 |
Brudasca, I; Cucuianu, M; Stancu, A; Trif, I | 1 |
Boldt, J; Heesen, M; Hempelmann, G; Heyn, S; Müller, M | 1 |
Lawrie, AS; Machin, SJ; Mackie, IJ; McDonald, SJ; Purdy, G | 1 |
1 review(s) available for fibrinogen and Critical Illness
Article | Year |
---|---|
Coagulation Dysfunction Criteria in Critically Ill Children: The PODIUM Consensus Conference.
Topics: Blood Coagulation Disorders; Child; Critical Illness; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; International Normalized Ratio; Multiple Organ Failure; Platelet Count; Severity of Illness Index | 2022 |
4 trial(s) available for fibrinogen and Critical Illness
Article | Year |
---|---|
Predictors of Inadequate Linezolid Concentrations after Standard Dosing in Critically Ill Patients.
Topics: Aged; Anti-Bacterial Agents; Body Weight; Creatinine; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Female; Fibrin; Fibrinogen; Humans; Lactic Acid; Linezolid; Male; Middle Aged; Models, Statistical; Multivariate Analysis; Prospective Studies; Respiratory Distress Syndrome; Risk Factors | 2016 |
First day dynamic changes in antithrombin III activity after supplementation have a predictive value in critically ill patients.
Topics: Adult; Aged; Anticoagulants; Antithrombin III; Critical Illness; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Regression Analysis; Retrospective Studies; Time Factors | 2006 |
Fibrinogen and markers of fibrinolysis and endothelial damage following resolution of critical limb ischaemia.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Viscosity; Critical Illness; Endothelium, Vascular; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Ischemia; Leg; Male; Middle Aged; Prospective Studies; von Willebrand Factor | 1995 |
Does long-term continuous administration of pentoxifylline affect platelet function in the critically ill patient?
Topics: Adult; Critical Illness; Double-Blind Method; Female; Fibrinogen; Humans; Infusions, Intravenous; Male; Middle Aged; Multiple Trauma; Pentoxifylline; Phosphodiesterase Inhibitors; Platelet Aggregation; Prospective Studies; Sepsis; Time Factors | 1996 |
38 other study(ies) available for fibrinogen and Critical Illness
Article | Year |
---|---|
Hematologic parameters and biomarkers predictors of severity in Multisystem Inflammatory Syndrome in children associated with SARS-CoV-2.
Topics: Biomarkers; C-Reactive Protein; Child; Clinical Deterioration; COVID-19; Critical Illness; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Leukocytes; Male; Neutrophils; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome; Thrombocytopenia | 2021 |
Prognostic value of fibrinogen to albumin ratios among critically ill patients with acute kidney injury.
Topics: Acute Kidney Injury; Albumins; Critical Illness; Fibrinogen; Humans; Intensive Care Units; Prognosis | 2022 |
Insights into Fibrinogen-Mediated COVID-19 Hypercoagubility in Critically Ill Patients.
Topics: COVID-19; Critical Illness; Fibrinogen; Fibrinolysis; Humans; SARS-CoV-2; Tissue Plasminogen Activator | 2022 |
Cytokine Adsorption in Critically Ill COVID-19 Patients, a Case-Control Study.
Topics: Adsorption; Case-Control Studies; COVID-19; Critical Illness; Cytokines; Fibrinogen; Humans; Intensive Care Units; Retrospective Studies | 2022 |
Hematologic System Dysregulation in Critically Ill Septic Patients with Anemia-A Retrospective Cohort Study.
Topics: Anemia; Blood Coagulation Disorders; Critical Illness; Fibrinogen; Humans; Intensive Care Units; Retrospective Studies; Sepsis | 2022 |
Fibrinogen and antithrombin III are associated with in-hospital mortality among critically ill patients with acute kidney injury.
Topics: Acute Kidney Injury; Anticoagulants; Antithrombin III; Cohort Studies; Critical Illness; Fibrinogen; Hospital Mortality; Humans; Prognosis; Retrospective Studies | 2022 |
A novel interaction between extracellular vimentin and fibrinogen in fibrin formation.
Topics: COVID-19; Critical Illness; Extracellular Space; Fibrin; Fibrinogen; Hemostatics; Humans; Inflammation; Thrombosis; Vimentin | 2023 |
Fibrinogen Is Associated with Prognosis of Critically Ill Patients with Sepsis: A Study Based on Cox Regression and Propensity Score Matching.
Topics: Critical Illness; Fibrinogen; Humans; Prognosis; Propensity Score; Retrospective Studies; Sepsis | 2023 |
Multiplatform analyses reveal distinct drivers of systemic pathogenesis in adult versus pediatric severe acute COVID-19.
Topics: Adult; Child; COVID-19; Critical Illness; Cytokines; Fibrinogen; Humans; SARS-CoV-2 | 2023 |
Effect of Microecological Regulator Combined with Enteral Nutrition on Immune and Coagulation Function in Patients with Chronic Critical Illness.
Topics: Blood Coagulation; Chronic Disease; Critical Illness; Enteral Nutrition; Fibrinogen; Humans | 2023 |
Factors affecting continuous renal replacement therapy duration in critically ill patients: A retrospective study.
Topics: Acute Kidney Injury; Anticoagulants; Citrates; Citric Acid; Continuous Renal Replacement Therapy; Critical Illness; Fibrinogen; Heparin; Heparin, Low-Molecular-Weight; Humans; Renal Replacement Therapy; Retrospective Studies | 2023 |
Proteomic Analysis of Pediatric Hemophagocytic Lymphohistiocytosis: a Comparative Study with Healthy Controls, Sepsis, Critical Ill, and Active Epstein-Barr virus Infection to Identify Altered Pathways and Candidate Biomarkers.
Topics: Biomarkers; Child; Complement Factor B; Critical Illness; Epstein-Barr Virus Infections; Fibrinogen; Herpesvirus 4, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Proteomics; Sepsis | 2023 |
Relationship of thromboelastography and conventional clotting test values with severe bleeding in critically ill patients with coagulopathy: A prospective study.
Topics: Adult; Aged; Blood Coagulation Disorders; Blood Coagulation Tests; Cardiac Surgical Procedures; Critical Illness; Female; Fibrinogen; Hemorrhage; Humans; Intensive Care Units; International Normalized Ratio; Liver Failure; Male; Middle Aged; Partial Thromboplastin Time; Prospective Studies; Sensitivity and Specificity; Thrombelastography | 2019 |
Factor VIII and Functional Protein C Activity in Critically Ill Patients With Coronavirus Disease 2019: A Case Series.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Antithrombins; Betacoronavirus; C-Reactive Protein; Comorbidity; Coronavirus Infections; COVID-19; Critical Illness; Diabetes Mellitus; Dyslipidemias; Extracorporeal Membrane Oxygenation; Factor VIII; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hypertension; International Normalized Ratio; Male; Middle Aged; Obesity; Pandemics; Partial Thromboplastin Time; Pneumonia, Viral; Protein C; Prothrombin Time; Renal Dialysis; Renal Insufficiency, Chronic; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Thrombophilia | 2020 |
Analysis of prediction and early warning indexes of patients with COVID-19.
Topics: Adult; Bilirubin; Biomarkers; Case-Control Studies; COVID-19; Critical Illness; Early Diagnosis; Female; Fibrinogen; Humans; Lymphocyte Count; Male; Middle Aged; Neutrophils; Oxygen; Retrospective Studies; SARS-CoV-2 | 2020 |
Evaluation of Disseminated Intravascular Coagulation in Critically Ill Pediatric Hemato-oncology Patients with Septic Shock.
Topics: Adolescent; Child; Critical Illness; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematologic Diseases; Hospital Mortality; Humans; Intensive Care Units, Pediatric; Male; Neoplasms; Platelet Count; Prothrombin Time; Retrospective Studies; Severity of Illness Index; Shock, Septic; Tertiary Care Centers | 2020 |
Therapeutic plasma exchange in a critically ill Covid-19 patient.
Topics: Aged; Albumins; C-Reactive Protein; Combined Modality Therapy; COVID-19; Critical Illness; Cytokine Release Syndrome; Fibrinogen; Humans; Interleukin-6; Male; Oxygen; Oxygen Inhalation Therapy; Plasma Exchange; Pneumonia, Ventilator-Associated; Respiration, Artificial; Respiratory Distress Syndrome; Salvage Therapy; SARS-CoV-2; Solutions | 2021 |
Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Blood Coagulation Tests; COVID-19; Critical Illness; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lipoproteins; Male; Middle Aged; Pandemics; Platelet Count; Retrospective Studies; SARS-CoV-2; Thrombin; Thrombophilia; Tissue Plasminogen Activator; Vascular Endothelial Growth Factor A; Young Adult | 2021 |
Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.
Topics: Aged; Area Under Curve; Betacoronavirus; Blood Coagulation Factor Inhibitors; Blood Coagulation Factors; Body Mass Index; Coronavirus Infections; COVID-19; Critical Illness; Factor V; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Pandemics; Pneumonia, Viral; Protein C; Protein S; ROC Curve; SARS-CoV-2; Venous Thromboembolism | 2020 |
Transfusion with Cryoprecipitate for Very Low Fibrinogen Levels Does Not Affect Bleeding or Survival in Critically Ill Cirrhosis Patients.
Topics: Afibrinogenemia; Biomarkers; Blood Transfusion; Critical Illness; Down-Regulation; Esophageal and Gastric Varices; Factor VIII; Female; Fibrinogen; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Intensive Care Units; Liver Cirrhosis; Male; Middle Aged; Patient Admission; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2021 |
Major bleeding complications in critically ill patients with COVID-19 pneumonia.
Topics: Aged; Anticoagulants; Biomarkers; Blood Coagulation; COVID-19; Critical Illness; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Humans; Inflammation Mediators; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome | 2021 |
Fibrinogen Level Predicts Outcomes in Critically Ill Patients with Acute Exacerbation of Chronic Heart Failure.
Topics: Aged; Aged, 80 and over; Biomarkers; Critical Illness; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Treatment Outcome | 2021 |
The relation between fibrinogen level, neutrophil activity and nucleosomes in the onset of disseminated intravascular coagulation in the critically ill.
Topics: Critical Illness; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Neutrophils; Nucleosomes; Thrombocytopenia | 2021 |
Combined Biomarkers Predict Acute Mortality Among Critically Ill Patients With Suspected Sepsis.
Topics: Aged; alpha-Macroglobulins; Biomarkers; C-Reactive Protein; Cohort Studies; Critical Illness; Ferritins; Fibrinogen; Haptoglobins; Hospital Mortality; Humans; Male; Middle Aged; Predictive Value of Tests; Procalcitonin; Sepsis; Serum Amyloid A Protein; Serum Amyloid P-Component; Tissue Plasminogen Activator | 2018 |
Clinical use of cryopoor plasma continuous rate infusion in critically ill, hypoalbuminemic dogs.
Topics: Animals; Critical Care; Critical Illness; Dog Diseases; Dogs; Factor VIII; Female; Fibrinogen; Hypoalbuminemia; Infusions, Intravenous; Male; Retrospective Studies; Serum Albumin | 2019 |
High-dose tigecycline-associated alterations in coagulation parameters in critically ill patients with severe infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Blood Coagulation Disorders; Critical Illness; Female; Fibrinogen; Humans; Male; Middle Aged; Minocycline; Partial Thromboplastin Time; Tigecycline | 2015 |
Comparison of point-of-care hemostatic assays, routine coagulation tests, and outcome scores in critically ill patients.
Topics: Aged; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Critical Care; Critical Illness; Female; Fibrinogen; Hemostasis; Humans; Intensive Care Units; Male; Organ Dysfunction Scores; Partial Thromboplastin Time; Platelet Count; Point-of-Care Systems; Prognosis; Prospective Studies; Thrombelastography | 2015 |
The Use of Ferritin to Identify Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis.
Topics: Aged; Biomarkers; Critical Illness; Female; Ferritins; Fibrinogen; France; Hospital Mortality; Humans; Intensive Care Units; L-Lactate Dehydrogenase; Lymphohistiocytosis, Hemophagocytic; Male; Megakaryocytes; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Sensitivity and Specificity; Sepsis; Simplified Acute Physiology Score; Thrombocytopenia | 2016 |
Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots.
Topics: Biomechanical Phenomena; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Critical Illness; Elastic Modulus; Fibrinogen; Hemostasis; Humans; Platelet Count | 2008 |
Recombinant activated factor VII use in critically ill infants with active hemorrhage.
Topics: Blood Component Transfusion; Critical Care; Critical Illness; Factor VIIa; Factor VIII; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Infant; Male; Postoperative Hemorrhage; Recombinant Proteins; Retrospective Studies; Venous Thrombosis | 2008 |
Non-overt disseminated intravascular coagulation scoring for critically ill patients: the impact of antithrombin levels.
Topics: Adult; Aged; Algorithms; Antithrombins; Biomarkers; Critical Illness; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hospital Mortality; Humans; Intensive Care Units; Japan; Logistic Models; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Prognosis; Prothrombin Time; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; ROC Curve; Severity of Illness Index; Time Factors | 2009 |
The effect of four hemostatic gene polymorphisms on the outcome of septic critically ill patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Critical Illness; Factor V; Factor XIII; Female; Fibrinogen; Genotype; Hemostasis; Humans; Male; Middle Aged; Mutation; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Prospective Studies; Sepsis; Shock, Septic; Young Adult | 2010 |
Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Albumins; alpha 1-Antitrypsin; beta 2-Microglobulin; Biomarkers; Cohort Studies; Collagen Type I; Critical Illness; Female; Fibrinogen; Humans; Intensive Care Units; Longitudinal Studies; Male; Middle Aged; Peptides; Prognosis; Proteomics; Sensitivity and Specificity | 2010 |
Concentration-dependent effect of hypocalcaemia on mortality of patients with critical bleeding requiring massive transfusion: a cohort study.
Topics: Acidosis; Adult; Aged; Blood Platelets; Blood Transfusion; Calcium; Cohort Studies; Critical Illness; Female; Fibrinogen; Hemorrhage; Hospital Mortality; Humans; Hypocalcemia; Male; Middle Aged; Odds Ratio; Prospective Studies; Risk Factors; Severity of Illness Index | 2011 |
Factors associated with prophylactic plasma transfusion before vascular catheterization in non-bleeding critically ill adults with prolonged prothrombin time: a case-control study.
Topics: Aged; Bilirubin; Blood Component Transfusion; Case-Control Studies; Catheterization, Central Venous; Catheterization, Peripheral; Cohort Studies; Critical Care; Critical Illness; Erythrocyte Transfusion; Female; Fibrinogen; Humans; Liver Diseases; Male; Middle Aged; Partial Thromboplastin Time; Plasma; Platelet Count; Prospective Studies; Prothrombin Time; United Kingdom | 2012 |
Acute phase proteins do not account for unmeasured anions in critical illness.
Topics: Acid-Base Equilibrium; Acid-Base Imbalance; Adult; Aged; Anions; Blood Gas Analysis; C-Reactive Protein; Carbon Dioxide; Computer Simulation; Critical Illness; Data Interpretation, Statistical; Female; Fibrinogen; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Predictive Value of Tests; Prospective Studies | 2007 |
Clinical studies on plasma protein C. Correlation with serum cholinesterase.
Topics: Adult; Aged; Aged, 80 and over; Cholestasis; Cholesterol; Cholinesterases; Critical Illness; Female; Fibrinogen; Humans; Hypertriglyceridemia; Liver Cirrhosis; Male; Middle Aged; Nephrotic Syndrome; Obesity; Protein C; Triglycerides | 1993 |
Prothrombin time derived fibrinogen determination on Sysmex CA-6000.
Topics: Animals; Anticoagulants; Critical Illness; Fibrinogen; Hemoglobinopathies; Humans; Kidney Diseases; Liver Diseases; Prothrombin Time; Rabbits; Reference Values; Statistics, Nonparametric | 1998 |